14 November 2019 - A Trump administration requirement that drug companies include their products’ list prices in TV ads is “overreach, plain and simple,” three drugmakers are arguing in urging a federal appeals court to uphold a ruling that struck down the rule.

Merck, Eli Lilly and Amgen in a brief filed with the U.S. Court of Appeals for the District of Columbia Circuit on Tuesday said U.S. Department of Health and Human Services lacked authority to establish the rule.

Read Reuters article